Could stopping oxygen therapy earlier get bronchiolitis babies home sooner?
NCT ID NCT06321133
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at two ways to end high flow nasal cannula treatment in infants with acute bronchiolitis. One group stops the high flow immediately, while the other gradually reduces it. The goal is to see if immediate stopping shortens hospital stays without causing more breathing problems or readmissions. About 50 infants will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- High flow nasal cannula therapy
- What this could lead to
- If immediate stopping works, it could shorten hospital stays for infants with bronchiolitis, reducing stress on families and hospitals.
- What could go wrong
- This is a small, early-stage trial with only 50 infants. Immediate stopping might lead to more treatment failures or readmissions, so results may not be widely applicable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE BRONCHIOLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Central Finland Hospital District
RECRUITINGJyväskylä, Finland
-
Kuopio University Hospital
RECRUITINGKuopio, Finland
-
Mikkeli Central Hospital
RECRUITINGMikkeli, Finland
-
Siun Sote
RECRUITINGJoensuu, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.